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AbstrAct
Objectives In older adults, there is a blunted 
responsiveness to resistance training and reduced 
muscle hypertrophy compared with younger adults. There 
is evidence that both exercise training and vitamin D 
supplementation may benefit musculoskeletal health in 
older adults, and it is plausible that in combination their 
effects may be additive. The aim of this systematic review 
was to evaluate the effectiveness of combined resistance 
exercise training and vitamin D3 supplementation on 
musculoskeletal health in older adults.
Data sources A comprehensive search of electronic 
databases, including Science Direct, Medline, PubMed, 
Google Scholar and Cochrane Central Register of 
Controlled Trials (Cochrane CENTRAL accessed by Wiley 
Science) was conducted. Eligible studies were randomised 
controlled trials including men and women (aged ≥65 
years or mean age ≥65 years); enlisting resistance 
exercise training and vitamin D3 supplementation; 
including outcomes of muscle strength, function, muscle 
power, body composition, serum vitamin D/calcium status 
or quality of life comparing results with a control group. 
The review was informed by a preregistered protocol 
(http://www. crd. york. ac. uk/ PROSPERO/ display_ record. 
asp? ID= CRD42015020157).
Results Seven studies including a total of 792 
participants were identified. Studies were categorised 
into two groups; group 1 compared vitamin D3 
supplementation and exercise training versus exercise 
alone (describing the additive effect of vitamin D3 
supplementation when combined with resistance 
exercise training) and group 2 compared vitamin D3 
supplementation and exercise training versus vitamin D3 
supplementation alone (describing the additive effect of 
resistance exercise training when combined with vitamin 
D3 supplementation). Meta-analyses for group 1 found 
muscle strength of the lower limb to be significantly 
improved within the intervention group (0.98, 95% CI 0.73 
to 1.24, p<0.001); all other outcomes showed small but 
non-significant positive effects for the intervention group. 
The short physical performance battery (SPPB), timed 
up and go (TUG), muscle strength of the lower limb and 
femoral neck bone mineral density showed significantly 
greater improvements in the intervention group for group 
2 comparisons.
Conclusions This review provides tentative support for 
the additive effect of resistance exercise and vitamin D3 
supplementation for the improvement of muscle strength 
in older adults. For other functional variables, such as 
SPPB and TUG, no additional benefit beyond exercise 
was shown. Further evidence is required to draw firm 
conclusions or make explicit recommendations regarding 
combined exercise and vitamin D
3 supplementation.
IntroductIon
Sarcopenia, originally defined as the 
age-related loss of muscle mass,1 now also 
encompasses low muscle strength and/or 
muscle function.2 The efficacy of resistance 
training in preventing or alleviating age-re-
lated musculoskeletal loss is well established; 
cited as the most promising intervention for 
improving symptoms of sarcopenia.3
Clear evidence exists demonstrating an 
association between resistance exercise 
training (RET) and muscle hypertrophy, 
which is maintained in older age.3–5 However, 
in older adults there is a blunted respon-
siveness to RET in comparison with younger 
adults; a blunted muscle protein synthetic 
rate in response to a single bout of resis-
tance exercise has been reported,6 and 
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Strengths and limitations of this study
 ► To the best of our knowledge, this study represents 
the first review evaluating the combined effects of 
vitamin D3 supplementation and exercise in older 
adults.
 ► Generally, outcome measure data could be graded 
as representing moderate quality.
 ► Only seven studies were found to be eligible for 
inclusion, highlighting the lack of literature available 
on the topic.
 ► The inclusion of one high-risk study was deemed 
necessary due to the lack of eligible studies.
group.bmj.com on July 23, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Antoniak AE, Greig CA. BMJ Open 2017;7:e014619. doi:10.1136/bmjopen-2016-014619
Open Access 
others demonstrate a reduction in muscle hypertrophy 
in comparison to younger adults.7–10 This ‘anabolic resis-
tance’ may be due to changes in gene expression and 
anabolic signalling; an attenuated anabolic hormone 
response to resistance exercise is observed in comparison 
to younger adults.11
Losses in muscle strength are associated with losses in 
functional ability, independence and increases in frailty, 
falls and disability in older adults12–15; therefore, there 
may be merit associated with a combination of interven-
tions to boost responsiveness of older muscle to resistance 
exercise and combat anabolic resistance.
Vitamin D3 supplementation in humans has been 
shown to positively influence musculoskeletal health in 
older adults: increases in relative number and cross-sec-
tional area (CSA) of muscle fibres (type II in particular) 
has been reported,16–18 and muscle strength increased 
and fall rates decreased after treatment with vitamin 
D3.
17 Vitamin D receptor concentration significantly 
increased with vitamin D3 supplementation
18; conversely, 
supplementation conferred no benefits on strength, 
functioning and balance.19–21 Moreover, a systematic 
review examining the effects of vitamin D3 supplementa-
tion in vitamin D replete adults aged over 18 years found 
no significant effect on grip or proximal lower limb 
muscle strength; however, pooled data including vitamin 
D deficient participants (serum 25(OH)D <25 nmol/L) 
demonstrated a large effect on hip muscle strength.22
There is conflicting evidence surrounding the efficacy 
of vitamin D3 supplementation alone or in combination 
with exercise on musculoskeletal health, with no clear 
consensus regarding the management or prevention of 
sarcopenia. Although epidemiological data suggest a 
relationship between vitamin D3 and muscle weakness,
23 
this association is not well understood, and evidence in 
published literature is lacking and contradictory. Consid-
ering the beneficial effects of both RET and vitamin D3 
on muscle tissue, it is plausible an additive effect would 
exist if combined, optimising the potential for healthy 
ageing muscle.24 Thus, the aim of this study was to assess 
the combined effect of RET and vitamin D3 supplementa-
tion on musculoskeletal health in older adults.
MaterIals and Methods
A systematic review of peer-reviewed literature relating 
to the effect of RET and vitamin D3 supplementation on 
musculoskeletal health in older adults was conducted in 
accordance with a study protocol registered on the PROS-
PERO database (record number CRD42015020157). The 
protocol was informed by the Cochrane Handbook for 
Systematic Reviews of Interventions,25 and reporting 
conformed to the Preferred Reporting Items for System-
atic Reviews and Meta-analysis statement.26
eligibility criteria
Randomised controlled trials were sought for this study. 
Journal studies included: (1) male and/or female 
participants (aged ≥65 years or mean age ≥65 years), (2) 
enlisted RET and vitamin D3 supplementation (studies 
using vitamin D3 and calcium supplementation were 
included), (3) included measures of muscle strength, 
function, muscle power, body composition, serum vitamin 
D/calcium status or quality of life, (4) compared results 
with a control group (sedentary/usual care/no vitamin 
D3 supplementation). Articles were excluded if partici-
pants were supplemented with additional protein or any 
supplement/medication with a known anabolic effect on 
muscle tissue.
search methods for identification of studies
Articles published before March 2016 were included. 
A computerised search of Science Direct, Medline, 
PubMed, Google Scholar and Cochrane Central Register 
of Controlled Trials (Cochrane CENTRAL accessed by 
Wiley Science) databases was conducted. Table 1 shows 
the Medline search strategy, devised by AEA and LH.
data items and collection
Data were extracted independently by two reviewers (AEA 
and ASA) using a standardised data extraction sheet; any 
disagreements were discussed and resolved with a third 
person (CAG). The inter-rater reliability assessed using 
Cohen’s Kappa, was found to be excellent (86% agree-
ment).27 Data items including general information, 
participant characteristics and details of the intervention 
were extracted. For key outcomes, the definition used 
by the authors, methodology, results, mean differences 
and the presence/absence of statistical significance were 
reported.
risk of bias analysis
Two reviewers (AEA and CAG) independently assessed 
the validity of included studies, with provisions for moder-
ation from a third reviewer. The Cochrane Collaboration’s 
tool for assessing risk of bias was used, as described in 
the Cochrane Handbook for Systematic Reviews of Inter-
ventions25 ; the use of scales for assessment is explicitly 
discouraged.28 29 Prespecified consensus points were 
devised and agreed by reviewers to ensure consistency. It 
was acknowledged that by nature of design, blinding of 
participants and personnel would be difficult in certain 
studies; therefore, grading was based on the likelihood 
that outcome measures were influenced by the potential 
lack of blinding.25
Grading the quality of evidence
The Grading of Recommendation, Assessment, Devel-
opment, and Evaluation (GRADE) handbook30 was used 
to evaluate the quality of evidence of outcomes assessed 
within the meta-analyses. The GRADE approach uses 
systematically produced questions to reach conclusions 
on degree of confidence in the estimate of the effect. 
GRADE assesses patient important outcomes across five 
areas: risk of bias, inconsistency, indirectness, impre-
cision and publication bias and grades outcomes as 
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Table 1 Example Ovid Medline search, to be adapted for other databases
1 Aging/
2 Exp aged/
3 (65 adj2 (years or age* or old*))
4 (old* adj (adult* or people or person* or population* or men or women))
5 (elder* or senior* or geriatric* or ?enarian or ag?ing)
6 ((age* or aging or old* or elder*) adj1 (musc*))
7 1 or 2 or 3 or 4 or 5 or 6
8 Vitamin D/
9 (cholecalciferol* or calciferol* or ergocalciferol*)
10 (supplements or dietary supplements)
11 ((vitamin D* or cholecalciferol or calciferol* OR ergocalciferol) adj supplementation)
12 8 or 9 or 10 or 11
13 Muscle Development/
14 Muscle, Skeletal/
15 (Skeletal muscle adj2 (atrophy or sarcopenia or wasting or loss or deterioration))
16 Muscle Strength/
17 (skeletal muscle mass or size or fibres or fibers or area)
18 (musc* adj2 (function* or power or strength))
19 (musc* adj2 (grow* or hypertrophy or size or mass or csa or cross sectional area or volume))
20 Body Composition/
21 (lean adj3 mass)
22 (protein adj2 (turnover or synthesis or breakdown))
23 (nitrogen adj2 (balance or turnover or synthesis or breakdown or retention or loss or retain*))
24 Sarcopenia/
25 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
26 Exp exercise/
27 (resistance exercise or resistance exercise training)
28 ((resistance or strength or weight or cardio or aerobic) adj3 (train* or condition* or exercise* or lift*))
29 (physical adj3 (activit* or exercise* or train* or exertion* or endurance* or therap* or conditioning or fitness))
30 (exercise adj3 (train* or intervention* or protocol* or program* or therap* or regim* or activit*))
31 26 or 27 or 28 or 29 or 30
32 7 and 12 and 25 and 31
33 Limit 32 to humans
34 Remove duplicates from 33
demonstrating high, moderate, low or very low quality of 
evidence.
results
study selection
Seven studies were included within the review: Agergaard 
et al31, Bunout et al32, Drey et al33, Gianoudis et al34, Jessup 
et al35, Uusi-Rasi et al21 and Verschueren et al36; the study 
flow diagram is presented in figure 1.
On reading full-text articles, it became clear that there 
were two separate groups of interventions; group 1, in 
which all participants took part in RET and the interven-
tion arm was supplemented with vitamin D3 (describing 
the additive effect of vitamin D3 supplementation when 
combined with resistance exercise training), group 2 in 
which all participants were supplemented with vitamin D3 
and the intervention arm took part in RET (describing 
the additive effect of resistance exercise training when 
combined with vitamin D3 supplementation); and studies 
using a combination of the two interventions (table 2).
study demographics
Seven eligible studies included a total of 792 participants 
of mean age 72.8 years (table 2). Of these, one included 
only males31 and three included only females.21 35 36 All 
studies included healthy participants living independently, 
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Figure 1 Study flow chart.
except for two studies35; included participants living 
within a retirement community and36 included institu-
tionalised participants living in nursing homes, service 
flats or cloistered communities.
Interventions
Studies assigned to group 1 included: Agergaard et 
al31, Bunout et al32 and Uusi-Rasi et al21. In group 1, all 
participants took part in RET; incorporating a warm-up 
and strengthening exercises using commercial weight 
machines21 31 or Thera-bands.31 Two studies included 
balance challenging aspects.21 32 All studies included 
supervised, progressive exercise sessions; progression 
was monitored by a five rep max test,31 Borg scale32 or 
metabolic equivalents (METs).21 Total number of sessions 
delivered ranged from 3631 to 156,21 over a duration of 
16 weeks31 to 24 months.21 All administered a vitamin D3 
supplement, orally in tablet form; doses ranged from 400 
IU/day32 to 1920 IU/day31 ; in two studies participants 
were supplemented with 800 mg calcium per day31 32 
and one study supplemented the control group with a 
placebo.21
Six studies assigned to group 2 included: Bunout et al32, 
Drey et al33, Gianoudis et al34, Jessup et al35, Uusi-Rasi et al21 
and Verschueren et al36. Within group 2, all participants 
took a vitamin D3 supplement, orally in tablet form. Doses 
ranged from 400 IU/day32 35 to 2000 IU/day33; one study 
monitored serum 25(OH)D at baseline to determine 
supplement dosage.33 In four studies,32 34–36 all partici-
pants were supplemented with calcium; doses ranged 
from 700 mg/day34 to 1000 mg/day35 36. The intervention 
group took part in RET. Studies used machine weights and 
pulleys,21 33–35 Thera-bands,32 weighted vests35 and whole 
body vibration machines36 for resistance. Five studies 
included balance challenging aspects.21 32–35 All studies 
employed supervised, progressive exercise sessions moni-
tored via a Borg scale,32–34 addition of weights to weighted 
vests,35 estimation of METs or individual ability.36 Total 
number of sessions delivered ranged from 2433 to 156,21 
over a duration of 12 weeks33 to 24 months.21 Note that 
two studies included comparators which allowed alloca-
tion to both groups.21 32
outcome measures
All outcomes are listed in table 3. Group 1 studies 
had few outcomes in common; however, all measured 
muscle strength21 31 32; isometric knee extensor strength 
was measured using a strain gauge21 31 and isometric 
quadriceps strength was measured using a quadriceps 
table.32 Hand grip strength was measured using a hand 
grip dynamometer.32 MRI was used to measure the CSA 
of the quadriceps,31 while32 analysed fat and lean mass 
using dual-energy X-ray absorptiometry (DXA). Two 
studies measured timed up and go (TUG), femoral 
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Table 4 Summary of risk of bias analysis for each included study
Author, year
Components of risk of bias
Summary Comments on high-risk components1 2 3 4 5 6 7
Agergaard et al)31 L U L L U L L High (0)
Unclear (2)
Low (5)
N/A
Bunout et al32 L U U U U U U High (0)
Unclear (6)
Low (1)
N/A
Drey et al33 L L U U L L U High (0)
Unclear (3)
Low (4)
N/A
Gianoudis et al34 L U U U H L L High (1)
Unclear (3)
Low (3)
One high-risk component, 5
ITT analysis used, but no data entered for 
participants with missing data
Jessup et al35 L U U U U U L High (0)
Unclear (5)
Low (2)
N/A
Uusi-Rasi et al21 L U U U U L L High (0)
Unclear (4)
Low (3)
N/A
Verschueren et al36 L U U U U L L High (0)
Unclear (4)
Low (3)
N/A
ITT, intention to treat; N/A, not available.
neck and spine bone mineral density (BMD).21 32 One 
study analysed fibre type and muscle quality.31
Group 2 studies21 32 34 36 assessed lower limb 
strength32 35 and measured grip strength. Muscle 
power was measured as sit-to-stand transfer power33 
and the stair climb test.34 The short physical perfor-
mance battery (SPPB) was assessed by,32 34 and the 
TUG by.21 32 34 BMD of the femoral neck21 32 34–36 and 
spine21 32 34 35 were measured using DXA. Lean mass 
was measured using DXA32–34 and X-ray CT.36 Balance 
was assessed via the Romberg ratio,32 four-square step 
test,34 an AccuSway platform35 and backwards walking.21 
Other outcomes included endurance (12 min walk32), 
the 30 s sit-to-stand test,34 normal walking speed and the 
5-time chair stand test.21
risk of bias within studies
The risk of bias analyses are displayed in table 4. For all 
studies, a high proportion of components were assigned 
an unclear risk of bias due to insufficient information and 
the unknown effect on study outcome measures. Many 
studies reported insufficient information on concealment 
and blinding procedures, or whether procedures were in 
place in the event of unblinding. In total, six studies were 
judged to have an unclear risk of bias.21 31–33 35 36 Compo-
nent 1 was assessed as having a low risk of bias for all 
studies. One study was assessed as having an overall high 
risk of bias34 due to component 5, as no data were entered 
into the analyses for participants with missing data.
Grade analysis
The GRADE summary of findings for groups 1 and 2 are 
shown in tables 5 and 6.
Within group 1, all studies were evaluated as moderate 
quality of evidence; no serious risk of bias was detected. 
Due to the nature of the studies included within this 
review, no serious indirectness was detected; all outcomes 
were measured directly without the use of a surrogate. 
Publication bias was not detected, and due to the number 
of studies included, it was not possible to produce funnel 
plots for any outcomes. Although publication bias was 
‘not detected’, it is difficult to conclude that there was 
a complete absence of bias since studies with significant 
results are more likely to be published than those reporting 
null or non-significant results.25 Published, peer-reviewed 
articles were included in this review, since the Cochrane 
Handbook for Systematic Reviews of Interventions further 
suggests that the inclusion of unpublished studies may 
introduce additional bias, as these studies have not been 
strengthened by the peer-review process and may be of 
lower methodological quality.25 Reasons for downgrading 
the quality of evidence included serious inconsistency 
due to substantial heterogeneity, and serious imprecision 
due to CIs crossing the line of no effect.
Within group 2 studies, five outcomes were graded 
as high-to-moderate quality of evidence (SPPB, TUG, 
muscle strength of the lower limb, hand grip strength and 
BMD of the femoral neck). Remaining outcomes were 
graded as low or very low quality, meaning that one could 
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have little or very little confidence in the effect estimate. 
Common reasons for downgrading outcomes included a 
combination of serious risk of bias (due to the inclusion 
of study34), serious imprecision or serious inconsistency.
results of individual studies and synthesis of results
Results of the two groups of studies are reported sepa-
rately. Qualitative syntheses were conducted for studies 
with similar interventions and outcomes measures 
using RevMan V.5.3 software. Study outcomes reporting 
results in the same units were pooled using a fixed-effect 
meta-analysis. Effect sizes are expressed as percentage 
mean differences or standardised mean differences (when 
outcomes were measured using different methods), with 
95% CIs. Higher weighting was assigned to studies with 
smaller SD and a larger sample size.25 Analyses were 
completed from extracted data, where necessary data 
were estimated from statistics or figures, or requested 
from the authors of the article. Heterogeneity was assessed 
via Χ2 test (figures 2–14 and tables 5 and 6). One article36 
was not included in any of the quantitative analyses, since 
the exercise intervention modality was considered to be 
too dissimilar to compare with the other included arti-
cles. Within each group, there were outcomes unsuitable 
for quantitative synthesis, due to a lack of studies with 
common outcomes or aspects of studies too dissimilar for 
comparison; therefore, a narrative analysis was used.
Quantitative synthesis
Outcomes compared for group 1 included muscle 
strength of the lower limb, TUG and BMD of the femoral 
neck and spine (figures 2–5). Only muscle strength of the 
lower limb was found to be significant, with a large effect 
size in favour of the intervention group (figure 2; 0.98, 
95% CI 0.73, to 1.24, p<0.00001).
Group 2 comparisons included the SPPB (figure 6), TUG 
(figure 7), muscle strength of the lower limb (figure 8), 
hand grip strength (figure 9), weight (figure 10), lean 
mass (figure 11), fat mass (figure 12), BMD of the 
femoral neck (figure 13) and spine (figure 14). Of these 
outcomes, hand grip strength, weight, lean mass, fat mass 
and the BMD of the spine were found to be non-signif-
icant. However, SPPB score was more improved in the 
intervention group (1.09, 95% CI 0.15 to 2.03, p=0.02), 
with a significant and large effect. Similarly, TUG was 
significantly reduced within the intervention group 
(−1.57, 95% CI −2.50 to –0.64, p=0.0010). The results of 
the quantitative analysis also supported the combined 
intervention for muscle strength of the lower limb (2.69, 
95% CI 0.95 to 4.42, p=0.002), and BMD of the femoral 
neck (0.04, 95% CI 0.01 to 0.06, p=0.002).
Qualitative synthesis
Referring to the narrative synthesis guidelines provided 
by the Cochrane Consumers and Communication Review 
Group,37 it was appropriate to apply two steps listed; 
developing a preliminary synthesis and exploring the 
relationships within and between studies. To develop a 
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Figure 2 Group 1 analysis of muscle strength of the lower limb.
Figure 3 Group 1 analysis of the TUG test.
Figure 4 Group 1 analysis of BMD of the femoral neck.
Figure 5 Group 1 analysis of BMD of the spine.
Figure 6 Group 2 analysis of the SPPB test.
primary synthesis, results were systematically tabulated 
to identify patterns across studies (tables 7–9). Exploring 
the relationships between and within studies for group 
1, the control group in study31 demonstrated a signifi-
cant percentage increase in CSA of the quadriceps from 
baseline in comparison with the intervention group 
(+8.46% vs +4.94%, p<0.05).
Comparing primary outcomes for group 2, the 
percentage increase in isometric knee extensor strength 
for study36 was greater in the intervention group 
(+3.01% vs +0.11%), although not statistically significant. 
Muscle power was compared in studies33 and expressed as 
sit-to-stand transfer power and functional stair climbing 
muscle power, respectively34. Both studies reported a 
significant percentage increase in muscle power within 
the intervention groups, and smaller, non-significant 
increases within the control groups (sit-to-stand transfer 
power intervention group +8.00% vs +2.61%, p=0.017; 
functional stair climbing muscle power intervention 
group +10.51% vs +7.32%, p<0.05).
The 30 s sit-to-stand test showed significant favourable 
results for the combined intervention of exercise and 
vitamin D3 (+10.40% vs +6.20%, p<0.05). Within study,
21 
normal walking speed declined in both groups and the 
5-time chair stand time was improved non-significantly in 
both groups. The 12 min walk test in study32 was further 
improved within the control group, although this did not 
achieve statistical significance. The four-square step test, 
body sway and backward walking were significantly more 
improved in the intervention groups. Only Romberg 
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Figure 7 Group 2 analysis of the timed up and go test.
Figure 8 Group 2 analysis of the muscle strength of the lower limb.
Figure 9 Group 2 analysis of hand grip strength.
ratio showed the greatest improvement within the control 
group; Romberg ratio was decreased in comparison with 
the intervention group, although the results were non-sig-
nificant (+2.8% vs −0.60%).
For group 2 secondary outcomes, small and non-signif-
icant gains in appendicular lean mass were demonstrated 
in the intervention group of study.33 In study,36 muscle 
mass of the upper limb decreased non-significantly in 
both the intervention and control groups, although to 
a lesser extent in the intervention group. BMD of the 
femoral neck was gained in both groups, although by a 
higher percentage in the control group; both trends were 
non-significant.
In summary, meta-analyses for group 1 found muscle 
strength of the lower limb to be significantly improved 
within the intervention group (0.98, 95% CI 0.73 to 1.24, 
p<0.001). All other outcomes showed small but non-sig-
nificant positive effects for the intervention group. The 
SPPB, TUG, muscle strength of the lower limb and femoral 
neck BMD all showed significantly greater improvements 
in the intervention group for group 2 comparisons.
The narrative analysis revealed significant differences 
in body composition, muscle power, muscle function and 
balance. A significant percentage increase in quadriceps 
CSA was observed in the control group of study.31 The 
combined intervention of RET and vitamin D3 supple-
mentation resulted in a greater percentage increase in 
muscle strength and power, and a greater improvement 
in the 30 s sit-to-stand test, the four-square step test, body 
sway and backward walking. However, vitamin D3 supple-
mentation alone resulted in a greater improvement in the 
12 min walk test and Romberg ratio.
dIscussIon
The aim of this systematic review was to assess the 
combined effect of RET and vitamin D3 supplementation 
on musculoskeletal health in older adults. Only seven 
studies were eligible for inclusion, with a total of 792 
participants, highlighting the lack of available literature 
on the topic. Studies were categorised into two groups: 
studies in which all participants took part in RET and the 
intervention group was supplemented with vitamin D3, 
or studies in which all participants were supplemented 
with vitamin D3 and the intervention group took part in 
RET. Two studies were categorised into both group 1 and 
group 2.
Quantitative analysis
Data analysis conducted for this review included 
meta-analyses and narrative reviews. Meta-analyses for 
group 1 included muscle strength of the lower limb, TUG 
and BMD of both the femoral neck and spine. Evidence 
of additional benefit was shown for all outcomes within 
the intervention group; however, the effect size was small 
and non-significant for TUG and BMD of the femoral 
neck and spine. Muscle strength of the lower limb was 
the only significant outcome of group 1, with a large 
effect size observed within the intervention group (0.98, 
95% CI 0.73, to 1.24, p<0.00001). Although numerous 
studies have demonstrated the beneficial effect of 
RET on muscle strength in older adults,3–5 this result 
provides evidence that vitamin D3 supplementation may 
enhance these effects in older adults. Skeletal muscle 
myopathies associated with vitamin D deficiency are 
well documented,38 and symptoms of significant muscle 
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Figure 10 Group 2 analysis of total body weight.
Figure 11 Group 2 analysis of lean mass.
Figure 12 Group 2 analysis of fat mass.
Figure 13 Group 2 analysis of bone mineral density of the femoral neck.
Figure 14 Group 2 analysis of bone mineral density of the spine.
weakness are reversed with treatment of the deficiency.39 
A systematic review and meta-analysis reported a gain in 
lower extremity strength with vitamin D supplementa-
tion only in vitamin D deficient older adults; no effect 
was observed in replete adults.22 Similarly, no effect of 
vitamin D3 supplementation on isometric quadriceps 
strength was demonstrated after 6 months in vitamin D 
replete older adults.40 Interestingly, although the studies 
included within group 121 31 32 did not specify serum 
25(OH)D levels as inclusion/exclusion criteria, baseline 
and postintervention serum 25(OH)D were within the 
‘sufficient’ range (>30 nmol/L). A greater increase of 
muscle strength in replete older adults represents a novel 
finding of this review. Preliminary support for combined 
vitamin D supplementation and RET was demonstrated 
in a 3-month longitudinal study examining the effect 
of serum 25(OH)D and exercise training on functional 
performance in older men and women aged 65 years 
and over. No significant improvements in function 
were reported in participants with lower serum 25(OH)
D (<47.5 nmol/L); however, higher serum 25(OH)D 
(>67.5 nmol/L) was associated with greatest improve-
ments in functionality and muscle strength.41
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Table 7 Narrative analysis summary of findings for group 1 secondary outcome measures
Category Outcome measure
Assessment 
point Study
Intervention group % 
change from baseline
Control group % change 
from baseline
M SD N M SD N
Body 
composition
CSA of quadriceps 
muscles (cm2)
16 weeks Agergaard et al, 
201531
+4.94 5.28 7 +8.46* 6.80 10
Group 1 studies compared vitamin D3 supplementation and exercise training vs exercise alone.
* p < 0.05 
CSA, cross-sectional area.
Table 8 Narrative analysis summary of findings for group 2 primary outcome measures
Category Outcome
Assessment 
point Study
Intervention group % 
change from baseline
Control group % change 
from baseline
M SD N M SD N
Muscle 
strength
Isometric knee extensor 
strength (Nm)
6 months Verschueren et al, 
201136
+3.01 2.67 28 +0.11 3.18 28
Muscle 
power
Sit-to-stand transfer 
power (W)
12 weeks Drey et al, 201133 +8.99* 5.51 23 +2.61 2.49 22
Functional stair 
climbing muscle power 
(W)
12 months Gianoudis et al, 201434 +10.40* 13.00 81 +6.20 12.70 81
Muscle 
function
30 s sit-to-stand (n. 
stands)
12 months Gianoudis et al, 201434 +18.30* 23.60 81 +2.70 17.2 81
 5-time chair stand 
time (s)
24 months Uusi-Rasi et al, 201521 −6.95 2.50 102 −3.49 3.30 102
Normal walking speed 
(m/s)
24 months Uusi-Rasi et al, 201521 −1.80 0.20 102 −3.30 0.21 102
Endurance: 12 min walk 
(m)
9 months Bunout et al, 200632 +8.80 17.60 22 +20.90 27.70 24
Balance Romberg ratio (%) 9 months Bunout et al, 200632 +2.80 33.80 22 −0.60 35.80
Four-square step test 
(s)
12 months Gianoudis et al, 201434 −12.00* 14.10 81 −5.20 14.90 81
Body sway (cm) 32 weeks Jessup et al, 200335 −26.39* 0.52 9 +2.90 0.49 9
Backwards walking (% 
able to complete)
24 months Uusi-Rasi et al, 201521 +25.47* 13.59 102 +9.48 15.58 102
Group 2 compared vitamin D3 supplementation and exercise training vs vitamin D3 supplementation alone.
* p < 0.05 
Table 9 Narrative analysis summary of findings for group 2 secondary outcomes
Category
Outcome 
measure
Assessment 
point Study
Intervention group % change 
from baseline
Control group % change from 
baseline
M SD N M SD N
Body 
composition
Appendicular lean 
mass (kg)
12 weeks Drey et al, 
201133
+1.65 0.71 23 +0.00 0.87 22
Muscle mass of 
upper limb (cm3)
6 months Verschueren et 
al, 201136
−0.16 0.57 28 −0.25 0.38 28
BMD of femoral 
neck (g/cm2)
6 months Verschueren et 
al, 201136
+0.71 0.42 28 +0.99 0.51 28
Group 2 compared vitamin D3 supplementation and exercise training vs vitamin D3 supplementation alone.
BMD, bone mineral density.
This finding must be considered within the context of the 
risk of bias and GRADE analyses. The risk of bias analysis 
showed an overall unclear risk of bias for the included studies, 
and the GRADE analysis concluded that the evidenced was 
of moderate quality; however, serious inconsistency due 
to moderate heterogeneity (I2=70%) was detected. This 
heterogeneity may have been due to the differing dura-
tion of interventions (12 weeks to 24 months), differences 
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between measurement methodologies, differences between 
exercise regimens (although all adopted progressive RET), 
doses of vitamin D3 (400–1920 IU/day) or may indicate that 
these studies were unsuitable for comparison.
Significant effects for the SPPB, TUG, muscle strength 
of the lower limb and the BMD of the femoral neck 
were observed within the intervention groups of group 2 
studies; unsurprisingly, RET was found to have a positive 
influence. In a recent systematic review and meta-analysis, 
exercise significantly increased SPPB score and decreased 
TUG time, with large effect sizes (1.87 and −2.47 , respec-
tively42); similar results are reported within this review. 
Vitamin D is a regulator of BMD, proliferating calcium 
and phosphate absorption in the intestine and acting 
directly on bone cells.43 Vitamin D has previously been 
shown to influence BMD, fracture rate and risk44; studies 
of patients who have sustained a hip fracture typically 
demonstrated low serum vitamin D (≤30.0 nmol/L45). 
Supplementation of vitamin D and calcium has been 
shown to significantly decrease the rate of bone loss in 
the hip and spine.46 GRADE analyses for these outcomes 
concluded the quality of evidence to be high (SPPB and 
TUG) or moderate (muscle strength of the lower limb 
and BMD of the femoral neck).
Closer examination of the control groups within signif-
icant outcomes for group 2 was undertaken to evaluate 
the effect of vitamin D3 supplementation alone. Intrigu-
ingly, although the intervention groups (RET and vitamin 
D3 supplementation) showed evidence of benefit in 
number of outcomes, the control groups (vitamin D3 
supplementation alone) showed mixed, or even negative 
impacts on the same outcomes. SPPB score was decreased 
postintervention compared with baseline by 0.30% and 
0.50% in the control groups of studies32 and33, respec-
tively. Muscle strength of the lower limb and BMD of 
the femoral neck showed mixed results for the interven-
tion groups, with some studies reporting small increases 
and others reporting small losses (non-significant). 
Previous reports of the effect of vitamin D supplemen-
tation on muscle strength and physical functioning are 
mixed; the InCHIANTI study of people aged 65 years or 
over reported a significant association between serum 
25(OH)D<25 nmol/L and SPPB score.47 Similarly, a 
large prospective cohort of older adults aged 65 years 
or over found those with low (<25 nmol/L) 25(OH)D 
were significantly more likely to experience losses in grip 
strength and higher rates of appendicular lean mass loss 
compared with those with higher (>50 nmol/L) 25(OH)
D.23 Conversely, another large, prospective study found 
no association between serum 25(OH)D, walking speed 
and time for repeated chair stands.48 The TUG test time 
increased in all groups of study,32 and was significantly 
increased in the vitamin D without exercise group in 
study (p=0.01).21 Again, participants included in studies32 
and21 had sufficient serum 25(OH)D levels, indicating 
that supplementation in replete older adults may not 
confer additional benefits to neuromuscular function 
unless combined with exercise.
narrative analysis
Studies in group 121 31 32 had few body composition 
outcomes in common, therefore, a narrative analysis was 
conducted. The CSA of the quadriceps was analysed within 
study,31 and results showed that although the intervention 
group did experience a +4.94%, increase from baseline, 
the control group (not supplemented with vitamin D3) 
actually showed a significantly higher increase in quadri-
ceps CSA (+8.46%, p<0.05).
These results do not provide evidence for the additive 
effects of combined exercise training and vitamin D3. 
Other study groups have reported changes in muscle 
CSA consequent to RET, which are both smaller8 49 and 
comparable50 to those reported in study.31 Interestingly, 
study31 also assessed ‘muscle quality’ (muscle strength/
CSA), although non-significant, the intervention group 
improved their muscle quality to a greater degree than 
the control group (+9.61% vs +0.66% change from 
baseline), indicating an increased functionality of the 
muscle to produce force; conceptually more relevant in 
combatting the effects of sarcopenia than muscle size and 
strength alone.51
Results of the narrative analysis for group 2 showed 
that the combined intervention of RET and vitamin D3 
supplementation was significantly more beneficial than 
vitamin D3 supplementation alone for sit-to-stand transfer 
power, functional stair climbing muscle power, 30 s sit-to-
stand, 5-time chair stand, the four-square step test, body 
sway and backward walking. Only body sway was nega-
tively affected by vitamin D3 supplementation, although 
the within-group change was non-significant. Other 
outcomes of interest included normal walking speed, 
which deteriorated in both groups, the distance walked 
in 12 min and Romberg ratio, in which the control groups 
made the most improvement, although not significantly.
limitations
Few published studies were eligible for inclusion within 
this review, although this serves to highlight the knowl-
edge gap with respect to this topic. The inclusion of a 
high-risk study was deemed necessary due to the lack of 
available literature, although this had a negative effect 
on the perceived quality of evidence for the outcomes 
in which it was reported. Generally, outcome measure 
data could be graded as representing moderate quality, 
although there were several outcome measures graded 
as low or very low quality, due to the high variability of 
participant numbers, duration of interventions, exercise 
methodologies or differing vitamin D3 doses and period 
of supplementation employed within the studies. Further-
more, data produced from meta-analyses including 
study21 may have been skewed due to the high weighting 
assigned for this study as a result of the large number of 
participants recruited.
Of the individual studies included within this review, 
none reported inclusion/exclusion criterion for vitamin 
D status, and although at baseline serum vitamin D was 
not significantly different between the groups in five 
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studies,21 31–33 36 two studies reported no data for serum 
vitamin D preintervention or postintervention.34 35 
Additionally, analysis methods used within five studies 
included did not account for confounding factors,31–34 36 
and participants were not stratified on the basis of any 
characteristics in three studies,21 31 35 although these 
were single-sex studies. Unfortunately, several outcome 
measures were unsuitable for inclusion within the 
qualitative analysis due to differing measurement meth-
odologies used or too few outcome measures in common. 
A recent systematic review and meta-analysis investigating 
the effects of vitamin D on neuromuscular remodelling 
following exercise or injury similarly found few eligible 
studies and high levels of heterogeneity due to method-
ological differences, resulting in the authors to suggest 
more high-quality evidence is needed to reach a result 
that is conclusive.52
conclusIon
This review provides tentative support for the additive 
effect of combined RET and vitamin D3 supplementa-
tion for the improvement of muscle strength in older 
adults. For other aspects of musculoskeletal function, 
such as SPPB and TUG, no additional benefit beyond 
that gained from exercise training was found. This review 
showed no evidence of benefit of vitamin D3 supplemen-
tation alone, however, few studies were identified during 
the literature search, highlighting that further evidence 
is required to draw any firm conclusions or make explicit 
recommendations regarding vitamin D3 supplementa-
tion for musculoskeletal health and function in older 
adults.
Our recommendations to enable future studies to 
definitively answer questions regarding the additive 
effects of the combined vitamin D3 supplementation and 
RET include common outcomes relevant to the condi-
tion studied, for example, the SPPB, 400 m walk and gait 
speed are recommended to assess physical performance,53 
which would allow for a more detailed assessment of 
results. Additionally, exercise interventions of similar 
durations would allow for a more accurate comparison 
between studies; it has been suggested that interventions 
with older adults should be of a minimum duration of 
3 months to obtain significant differences in relevant 
outcomes.53 Reporting of confounding factors would 
allow for adjustment of results via the use of covariates, 
for example, objective measures of physical activity using 
accelerometers, baseline serum vitamin D3 status and 
participant characteristics, which may bias the participant 
pool. Separate analysis of male and female participants, 
or the addition of sex as a covariate in any analysis models 
would help to address sex-related differences in perfor-
mance. Regarding study design, four-armed RCT studies 
are best placed to answer combined effects research 
questions, that is, exercise intervention, vitamin D inter-
vention, both exercise and vitamin D, neither exercise 
nor vitamin D (true control). A true control group was 
lacking from a number of the included studies within this 
review.
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